Reverse seroconversion of hepatitis B in a haemodialysis patient
Open Access
- 1 January 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (1), 238-241
- https://doi.org/10.1093/ndt/gfg448
Abstract
The appearance of hepatitis B surface antibodies (anti-HBs) and hepatitis B core antibodies (anti-HBc) is considered as serological evidence of resolved infection with clearance of the hepatitis B virus (HBV). Viral reactivation in this situation (reverse seroconversion) is a rare, but well described complication in transplanted patients receiving immunosuppressive therapy [1,2], in patients subjected to cytotoxic chemotherapy [2,3], or in HIV infected individuals [2,4].Keywords
This publication has 9 references indexed in Scilit:
- Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver diseaseGastroenterology, 2001
- Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important roleJournal of Medical Virology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- REACTIVATION OF HEPATITIS B AFTER TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING ANTI-HEPATITIS B SURFACE ANTIGEN ANTIBODIESTransplantation, 1998
- A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis BHepatology, 1996
- Redevelopment of Hepatitis B Surface Antigen After Renal TransplantationGastroenterology, 1991
- Immunoselected hepatitis B virus mutantThe Lancet, 1991
- Recurrence and Clearance of Hepatitis B Surface Antigenemia in a Dialysis Patient Infected With the Human Immunodeficiency VirusAmerican Journal of Kidney Diseases, 1990
- RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTSThe Lancet, 1989